Literature DB >> 10755172

Neuropsychological function in mild hyperphenylalaninemia.

M L Smith1, J Saltzman, P Klim, W B Hanley, A Feigenbaum, J T Clarke.   

Abstract

Whether specific cognitive deficits related to frontal-lobe dysfunction that have been reported in individuals with phenylketonuria (PKU) are also characteristic of mild hyperphenylalaninemia (MHP) was investigated. Tests of executive function and control tasks not assessing executive function were administered to a group of individuals with MHP and a group without MHP, similar in age, gender, and IQ. Tests of academic skills and behavior-rating questionnaires were also administered to the group with MHP. No group differences were found for any measure, suggesting that the mild elevations of phenylalanine in individuals with MHP are not sufficient to produce behavioral and cognitive impairments characteristic of PKU.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10755172     DOI: 10.1352/0895-8017(2000)105<0069:NFIMH>2.0.CO;2

Source DB:  PubMed          Journal:  Am J Ment Retard        ISSN: 0895-8017


  6 in total

1.  Cognitive function in untreated subjects with mild hyperphenylalaninemia: a systematic review.

Authors:  Noushin Rostampour; Rojin Chegini; Silva Hovsepian; Farzaneh Zamaneh; Mahin Hashemipour
Journal:  Neurol Sci       Date:  2022-06-21       Impact factor: 3.830

Review 2.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

Review 3.  Mild hyperphenylalaninemia: to treat or not to treat.

Authors:  Francjan J van Spronsen
Journal:  J Inherit Metab Dis       Date:  2011-02-24       Impact factor: 4.982

4.  Cognitive functioning in mild hyperphenylalaninemia.

Authors:  Alicia de la Parra; María Ignacia García; Susan E Waisbren; Verónica Cornejo; Erna Raimann
Journal:  Mol Genet Metab Rep       Date:  2015-10-29

5.  Danger of high-protein dietary supplements to persons with hyperphenylalaninaemia.

Authors:  R Koch; K D Moseley; R Moats; S Yano; R Matalon; F Guttler
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.750

6.  Optical Coherence Tomography to Assess Neurodegeneration in Phenylalanine Hydroxylase Deficiency.

Authors:  Amelie S Lotz-Havla; Katharina Weiß; Katharina Schiergens; Stephanie Regenauer-Vandewiele; Klaus G Parhofer; Tara Christmann; Luise Böhm; Joachim Havla; Esther M Maier
Journal:  Front Neurol       Date:  2021-12-10       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.